All Press releases

April 23, 2019

Fulcrum Therapeutics Acquires Global Rights to Losmapimod, a Potential Disease-Modifying Therapy for Facioscapulohumeral Muscular Dystrophy

February 20, 2019

Fulcrum Therapeutics Appoints Christopher Moxham, Ph.D. as SVP, Discovery

January 4, 2019

Fulcrum Therapeutics to Present at Biotech Showcase 2019

January 3, 2019

Fulcrum Therapeutics Appoints Biotech Executive Bryan Stuart as Chief Operating Officer

September 5, 2018

Fulcrum Therapeutics Announces $80 Million Series B Financing

August 14, 2018

Fulcrum Therapeutics Promotes Diego Cadavid, M.D., to Senior Vice President, Clinical Development

June 27, 2018

Fulcrum Therapeutics Strengthens Board of Directors with Appointment of Kate Haviland

May 21, 2018

Fulcrum Therapeutics and the FSHD Clinical Trial Research Network Announce Clinical Trial Readiness Study

March 15, 2018

Fulcrum Therapeutics to Present at BioCentury’s Future Leaders in the Biotech Industry Conference

February 28, 2018

Fulcrum Therapeutics to Present at the 11th Annual Future of Genomic Medicine Conference

Next